Daily Archives: January 7, 2019

DXB Welcomes Billionth Passenger

DUBAI, United Arab Emirates, Jan. 07, 2019 (GLOBE NEWSWIRE) — Following the official announcement earlier today from HH Sheikh Mohammed bin Rashid Al Maktoum, Vice President & Prime Minister of…

Checkpoint Therapeutics Initiates Registrational Development Programs for Anti-PD-L1 Antibody CK-301

Ongoing endometrial and colorectal cancer cohorts intended to support BLA submissions NEW YORK, Jan. 07, 2019 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company…

Checkpoint Therapeutics Initiates Registrational Development Programs for Anti-PD-L1 Antibody CK-301

Ongoing endometrial and colorectal cancer cohorts intended to support BLA submissions NEW YORK, Jan. 07, 2019 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company…

Favored Tech Previews Groundbreaking Electronic Coating Tech at CES19

Patented Technology Makes Cell Phones Virtually Water Proof, Offers Comprehensive Protective Nano Coating for the Latest Electronic Devices LAS VEGAS, Jan. 07, 2019 (GLOBE NEWSWIRE) — Favored Tech, a leading…

Favored Tech Previews Groundbreaking Electronic Coating Tech at CES19

Patented Technology Makes Cell Phones Virtually Water Proof, Offers Comprehensive Protective Nano Coating for the Latest Electronic Devices LAS VEGAS, Jan. 07, 2019 (GLOBE NEWSWIRE) — Favored Tech, a leading…

Fertin Pharma Acquires Tab Labs – Provides the Combined Group a Unique CDMO Position in the North American Dietary Supplement Market

VEJLE, Denmark, Jan. 07, 2019 (GLOBE NEWSWIRE) — Fertin Pharma A/S (“Fertin Pharma”) has signed and closed the acquisition of Tab Labs Inc. (“Tab Labs”), a leader in compressed gum…

Axsome Therapeutics Announces AXS-05 Achieves Primary Endpoint in Phase 2 Trial in Major Depressive Disorder

Demonstrated statistically significant improvement in MADRS scores compared to active comparator (p<0.001 on primary endpoint) Rapid improvement in depressive symptoms demonstrating statistically significant superiority over active comparator within the first…

Fertin Pharma’s Parent Company Acquires MedCan Pharma – Allowing Entry into Fast-growing Market for Cannabinoid Products

VEJLE, Denmark, Jan. 07, 2019 (GLOBE NEWSWIRE) — Claudio Bidco A/S (the “Parent Company”), the parent company of Fertin Pharma A/S (“Fertin Pharma”) has signed and closed the acquisition of…